A nurse is teaching a newly licensed nurse about reducing the risk of needlestick injuries. Which of the following instructions should the nurse include?

A. Communicability refers to the ability of a pathogen, such as a virus, to spread from one person to another. If a virus undergoes a mutation that increases its communicability, it means that the virus can more readily transmit from an infected person to others. This could be due to changes in viral proteins that enhance attachment to host cells, increase viral shedding, or improve survival in the environment.
B. This statement describes the concept of the infectious dose, not communicability. Infectious dose refers to the amount of virus (or pathogen) required to establish an infection in a susceptible host. A mutation that lowers the infectious dose could potentially increase the likelihood of infection, but it does not directly relate to communicability.

C. Environmental stability refers to the ability of a virus to survive outside of a host and remain capable of causing infection. While environmental stability can contribute to the overall transmission of a virus, it does not specifically define communicability, which focuses on person-to-person spread.
D. Disease severity refers to the impact of infection on the health of an individual, ranging from mild symptoms to severe illness and potential mortality. A mutation that increases disease severity does not necessarily affect communicability unless severe disease leads to behaviors that enhance transmission (e.g., increased shedding of virus).

A. This response addresses the timeframe for heparin to achieve therapeutic levels in the bloodstream, not its action on dissolving clots. Heparin works primarily by inhibiting the formation of new clots and preventing existing clots from enlarging or propagating, rather than directly dissolving existing clots.
B. This statement accurately describes the mechanism of action of heparin. Heparin is an anticoagulant that works by enhancing the activity of antithrombin III, which inhibits the clotting factors thrombin and factor Xa. This action prevents the formation of new clots and stabilizes existing clots, but it does not actively dissolve them.
C. While pharmacists are knowledgeable about medications, including their mechanisms of action, it is within the scope of nursing practice to provide information on how medications work to clients. The nurse should be prepared to explain the basic mechanism of heparin's action to the client in understandable terms.
D. This response is inaccurate regarding heparin's action. Heparin itself does not directly dissolve clots; it prevents further clot formation and allows the body's natural fibrinolytic (clot-dissolving) mechanisms to work on existing clots. Oral medications like warfarin or direct oral anticoagulants (DOACs) may be used after initial heparin therapy to continue anticoagulation, but they do not directly dissolve clots either.